INTERVIEW: Cigna VP says outcome-based contracts are here to stay
This article was originally published in Scrip
Executive Summary
While outcomes-based contracts between US health plans and pharmaceutical companies are the exception rather than the rule, that's changing, and Cigna was one of the first to test a model of reimbursing the cost of medicines based on the health value to the patient and the economic value to the payer versus paying for a drug simply because a doctor wrote a prescription for it.